Skip to main content
Premium Trial:

Request an Annual Quote

Christopher Benoit

Christopher Benoit has been appointed as CEO of TwinStrand Biosciences after joining the company's board of directors earlier this year. Previously, he held various roles at Enzymatics, a company he co-founded. Qiagen acquired Enzymatis in 2014. He is also a member of the board of TangenDX, a point-of-care molecular diagnostics company.